Characterization of a gastric tumor cell line defective in MHC class I inducibility by both α- and γ-interferon

Tissue Antigens

Volumn 47, Issue 5, 1996, Pages 391-398

  Abril, E ^a   Mendez, R E ^a   Garcia A ^a   Serrano, A ^a   Cabrera, T ^a   Garrido, F ^a   Ruiz Cabello, F ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Interferon; Interferon consensus sequence; Major histocompatibility antigen

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSCRIPTION FACTOR;

ARTICLE; ELECTROPHORETIC MOBILITY; HISTOCOMPATIBILITY GENE; HLA SYSTEM; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NORTHERN BLOTTING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

EID: 0029924774     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02574.x     Document Type: Article

References (40)

1. Ploegh H, Orr H, Strominger J. Major histocompatibility antigens: the human (HLA-A,B,C) and murine (H-2K, H-2D) class I molecules. Cell 1981: 24: 287-91.
2. Burke PA, Hirschfeld S, Shirayoshi Y et al. Developmental and tissue-specific expression of nuclear proteins that bind the regulatory element in major histocompatibility complex class I genes. J Exp Med 1989: 169: 1309-21.
3. Hamada K, Gleason SL, Levi BZ, Hirschfeld S, Appella E, Ozato K. H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. Proc Natl Acad Sci U S A 1989: 86: 8289-93.
4. b promoter: enhancer-like sequence and their role in the regulation of class I gene expression. Cell 1986: 44: 261-5.
5. Korber B, Mermod L, Hood L, Stroynowski I. Regulation of gene expression by interferons: control of H-2 promoter responses. Science 1988: 239: 1302-6.
6. Haken R, Le Bouteiller P, Barad M et al. IFN-mediated differential regulation of the expression of HLA-B7 and HLA-A3 class I genes. J Immunol 1989: 142: 297-305.
7. Yano O, Kanellopoulus J, Kieran M, Le Bail O, Israel A, Kourislky P. Purification of KBF1, a factor binding to both H-2 and B2-microglobulin enhancers. EMBO J 1987: 6: 3317-24.
8. Baldwin AS, Sharp PA. Two transcriptional factors, NF-κB and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter. Proc Natl Acad Sci U S A 1988: 85: 723-5.
9. Fujita T, Nolan GP, Gosh S, Baltimore D. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB. Genes Devel 1992: 6: 775-87.
10. David-Watine B, Israel A, Kourilsky P. The regulation and expression of MHC class I genes. Immunol Today 1990: 8: 286-91.
11. Pfizenmaier K, Scheurich P, Schlüter C, Kronke, M. Tumor necrosis factor enhances HLA-A, B, C and HLA-DR gene expression in human tumor cells. J Immunol 1987: 138: 960-75.
12. Shirayoshi Y, Burke P, Appella E, Ozato. K. Interferon-induced transcription of a major histocompatibility class I gene accompanies binding of inducible nuclear factors to the interferon consensus. Proc Natl Acad Sci U S A 1988: 85: 5884-8.
13. Levy DE, Lew DJ, Decker T, Kessler DS, Darnell JE. Synergistic interaction between interferon alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J 1990: 9: 1105-11.
14. Levy DE, Kessler DS, Pine R, Reich N, Darnell JE. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Devel 1988: 2: 383-93.
15. Revel M, Chebath J. Interferon-activated genes. Trends Biochem Sci 1986: 11: 166-70.
16. Williams BRG. Transcriptional regulation of interferon-stimulated genes. Eur J Biochem 1991: 200: 1-11.
17. Loh JE, Chang WL, Fodor WL, Flavell RA. Dissection of the interferon-γ MHC class I signal transduction pathway reveals that type I and type II interferon systems share common signalling components. EMBO J 1992: 11: 1351-63.
18. Pine R, Canova A, Schindler C. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNα and IFNγ, and is likely to autoregulate the p91. EMBO J 1994: 13: 158-67.
19. Darnell JE, Kerr IM, Stark GR. Jak-stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994: 264: 1415-21.
20. Jule E, Mucke L, Oldstone MBA. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 1991: 253: 1283-5.
21. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern PL. Natural history of HLA expression during tumor development, Immunol Today 1993: 14: 491-9.
22. Garrido F, Ruiz-Cabello F. MHC expression on human tumors. Its relevance for local tumor growth and metastasis. Semin Cancer Biol 1991: 2: 3-10.
23. Barnstable CJ, Bodmer WF, Brown G et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens. New tools for genetic analysis. Cell 1978: 14: 9-20.
24. Lopez-Nevot MA, Cabrera T, De La Higuera B, Ruiz-Cabello F, Garrido F. Production and characterization of monoclonal antibodies against leukemic cells. Inmunologia 1986: 5: 51-9.
25. Blanchet O, Bourge JF, Zinszner H, Tatari Z, Degos L, Paul P. DNA binding of regulatory factors interacting with MHC-class-I gene enhancer correlates with MHC-class-I transcriptional level in class-I-defective cell lines. Int J Cancer 1991: 6: 138-45.
26. Chirgwin JM, Przybyla AE, MacDonald RJ, Ruter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979: 18: 5294-9.
27. Redondo M, Ruiz-Cabello F, Concha A et al. HLA-class-I expression in NSCLC is independent of c-myc activation. Cancer Res 1991: 51: 2463-8.
28. Koller BH, Sidwell B, Demars R, Orr HT. Isolation of HLA locus-specific DNA probes from the 3′-untranslated region. Proc Natl Acad Sci U S A 1984: 81: 5175-8.
29. Fryberg EA, Kindle KL, Davidson N, Kindle KL. The actin genes of Drosophila: a dispersed multigene family. Cell 1980: 19: 365-78.
30. Kolley BH, Orr HT. Cloning and complete sequence of an HLA-A2 gene analysis of two HLA-A alleles at the nucleotide level. J Immunol 1985: 134: 2727-33.
31. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977: 74: 5463-7.
32. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983: 11: 1475-89.
33. Rodriguez F, Perán F, Garrido F, Ruiz-Cabello F. Upmodulation by estrogen of HLA class I expression in breast tumor cell lines. Immunogenetics 1994: 39: 161-7.
34. Pestka S, Jerome AL, Zoon KC, Samuel CE. Interferons and their actions. Annu Rev Biochem 1987: 56: 727-77.
35. Israel A, Kimura A, Fournier A, Fellous M, Kourilsky P. Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature 1986: 322: 743-6.
36. b. EMBO J 1989: 8: 1139-44.
37. Sugita K, Miyazaki E, Appella E, Ozato K. Interferon increases transcription of a major histocompatibility class I gene via a 5′ interferon consensus sequence. Proc Natl Acad Sci U S A 1987: 7: 2625-31.
38. Kumar A, Haque S, Hiscott J, Willians BRG. The interferon induced p68 protein kinase regulates transcription factor NF-κB via phosphorylation of its inhibitor IκB. J Interferon Res 1992: 12: S207.
39. Müller M, Briscoe J, Laxton C et al. The protein tyrosine kinase Jak1 complements defects in interferon-α/β and -γ signal transduction. Nature 1993: 366: 129-35.
40. Dron M, Tovey MG. Interferon-resistant Daudi cells are deficient in interferon-alpha-induced ISGF3 alpha activation, but remain sensitive to the interferon-alpha-induced increase in ISGF3 gamma content. J Interferon Res 1993: 13: 377-83.